Inventor · North Chicago, IL, US

Thomas W. von Geldern

20Patents
9h-index
51Co-inventors
78Inventor score

Filing activity: Mar 2, 1992 → Apr 17, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US5326776A Angiotensin II receptor antagonists Chemistry; Metallurgy 57 Expired
US5767144A Endothelin antagonists Chemistry; Metallurgy 43 Expired
US8748412B2 Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators Chemistry; Metallurgy 28 Active
US5250548A Angiotensin II receptor antagonists Chemistry; Metallurgy 25 Expired
US6946481B1 Endothelin antagonists Chemistry; Metallurgy 17 Expired
US6162927A Endothelin antagonists Chemistry; Metallurgy 15 Expired
US7208517B1 Endothelin antagonists Human Necessities 14 Expired
US7365093B2 Endothelin antagonists Chemistry; Metallurgy 11 Expired
US6124341A Endothelin antagonists Human Necessities 11 Expired
US5622971A Endothelin antagonists Chemistry; Metallurgy 8 Expired
US6462194B1 Endothelin antagonists Chemistry; Metallurgy 8 Expired
US5731434A Endothelin antagonists Chemistry; Metallurgy 8 Expired
US6380241B1 Treatment of diseases using endothelin antagonists Chemistry; Metallurgy 7 Expired
US10072040B2 Tylosin A analogs and derivatives Human Necessities 1 Active
US9988368B1 Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use Chemistry; Metallurgy 1 Active
US7834012B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) Chemistry; Metallurgy 0 Active
US8377913B2 Vitamin D receptor activators and methods of making Chemistry; Metallurgy 0 Active
US10238677B2 Treatment of filarial diseases Emerging Cross-Sectional Technologies 0 Active
US10329279B2 Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use Chemistry; Metallurgy 0 Active
US11111259B2 Acylsulfonamide derivatives for treating senescence-associated diseases and disorders Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.